SYNARTRO

Synartro is a Swedish research and development company that develops improved treatments using patented delivery technology combined with existing proven drugs. The preclinical lead program, SYN321, is based on a novel therapy combining diclofenac covalently bound to hyaluronan for the treatment of osteoarthritis (OA), a disease that today leaves up to 50% of patients without adequate pain relief. The company’s initial focus is in knee OA with the potential of further expansion.

#People #Financial #Website #More

SYNARTRO

Industry:

Biotechnology Therapeutics

Founded:

2011-01-01

Address:

Uppsala, Uppsala Lan, Sweden

Country:

Sweden

Website Url:

http://www.synartro.com

Total Employee:

Status:

Active

Total Funding:

5.67 M EUR

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx PHP

Current Employees Featured

monika-vedin_image

Monika Vedin
Monika Vedin CEO @ Synartro
CEO

not_available_image

Magnus Hurst
Magnus Hurst Chief Financial Officer @ Synartro
Chief Financial Officer

fredrik-lehmann_image

Fredrik Lehmann
Fredrik Lehmann Founder & Chairman @ Synartro
Founder & Chairman

Founder

fredrik-lehmann_image

Fredrik Lehmann

Investors List

sciety_image

Official Site Inspections

http://www.synartro.com

Host Informations
Whois Informations

Loading ...